Thirteen Variations of Influenza Vaccines are now Approved for the 2013-14 Influenza Season!

Well Providers its that Influenza time of year again!!   Many of you have already been administering the Influenza Vaccines to your high risk patients.

Don’t forget to update the NDC numbers for each of your vaccines CPT codes before billing.  You will find these on your purchase invoice.  See the table below for the thirteen approved vaccines for the various age levels and types of strains.

 

Name	Manufacturer	Age Range	# of Strains
Afluria	Merck/CSL	9 years and older*	Trivalent
Fluarix	GSK	3 years and older	Trivalent
			Quadrivalent
Flublok	Protein Sciences	18 – 49 years	Trivalent
Flucelvax	Novartis	18 years and older	Trivalent
FluLaval	GSK	3 years and older	Trivalent
			Quadrivalent
FluMist	Medimmune	2 – 49 years	Quadrivalent
Fluvirin	Novartis	4 years and older	Trivalent
Fluzone	Sanofi Pasteur	6 months and older	Trivalent
			Quadrivalent
Fluzone High-Dose	Sanofi Pasteur	65 years and older	Trivalent
Fluzone Intradermal	Sanofi Pasteur	18 – 64 years	Trivalent

Influenza Virus Strains in the 2013-2014 Vaccines

• A/California/7/2009 (H1N1)-like
• A/Victoria/361/2011 (H3N2), or its antigenic equivalent
• B/Massachusetts/2/2012-like (Yamagata lineage)

Quadrivalent formulations will also include
B/Brisbane/60/2008-like (Victoria lineage)

Abbreviations used for influenza vaccines

• IIV: Inactivated Influenza Vaccine (Afluria, Fluarix, FluLaval, Fluvirin, Fluzone)
  (IIV3 = Trivalent IIV; IIV4 = Quadrivalent IIV)
• LAIV (Quadrivalent): Live, Attenuated Influenza Vaccine (FluMist)
• RIV3: Recombinant Influenza Vaccine, Trivalent (Flublok)
• ccIIV3: Cell Culture Inactivated Influenza Vaccine, Trivalent (Flucelvax)

Concurrent Administration

Influenza vaccines may be administered concurrently with other live or inactivated vaccines.

As always “Take Advantage” for all of your billing and practice software needs.  Phone 877.666.5279